Literature DB >> 29924938

Discoidin Domain Receptor 2, a Potential Therapeutic Target in Lung Fibrosis.

Corina M Borza1, Ambra Pozzi2, Erin J Plosa3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29924938      PMCID： PMC6189646          DOI： 10.1165/rcmb.2018-0161ED

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  14 in total

1.  Targeting of Discoidin Domain Receptor 2 (DDR2) Prevents Myofibroblast Activation and Neovessel Formation During Pulmonary Fibrosis.

Authors:  Hu Zhao; Huan Bian; Xin Bu; Shuya Zhang; Pan Zhang; Jiangtian Yu; Xiaofeng Lai; Di Li; Chuchao Zhu; Libo Yao; Jin Su
Journal:  Mol Ther       Date:  2016-05-27       Impact factor: 11.454

2.  Discoidin Domain Receptor 2 Signaling Regulates Fibroblast Apoptosis through PDK1/Akt.

Authors:  Shijing Jia; Manisha Agarwal; Jibing Yang; Jeffrey C Horowitz; Eric S White; Kevin K Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2018-09       Impact factor: 6.914

3.  Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liver-associated macrophages.

Authors:  Elvira Olaso; Beatriz Arteta; Aitor Benedicto; Olatz Crende; Scott L Friedman
Journal:  Am J Pathol       Date:  2011-10-19       Impact factor: 4.307

Review 4.  Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers.

Authors:  Moisés Selman; Annie Pardo
Journal:  Proc Am Thorac Soc       Date:  2006-06

Review 5.  Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute.

Authors:  Victor J Thannickal; Craig A Henke; Jeffrey C Horowitz; Paul W Noble; Jesse Roman; Patricia J Sime; Yong Zhou; Rebecca G Wells; Eric S White; Daniel J Tschumperlin
Journal:  Am J Pathol       Date:  2014-04-13       Impact factor: 4.307

6.  Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome.

Authors:  Lisa R Young; Peter M Gulleman; Chelsi W Short; Harikrishna Tanjore; Taylor Sherrill; Aidong Qi; Andrew P McBride; Rinat Zaynagetdinov; John T Benjamin; William E Lawson; Sergey V Novitskiy; Timothy S Blackwell
Journal:  JCI Insight       Date:  2016-10-20

7.  Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis.

Authors:  Carmel Avivi-Green; Mayank Singal; Wolfgang F Vogel
Journal:  Am J Respir Crit Care Med       Date:  2006-05-11       Impact factor: 21.405

Review 8.  The Role of Discoidin Domain Receptor 1 in Inflammation, Fibrosis and Renal Disease.

Authors:  Aude Dorison; Jean-Claude Dussaule; Christos Chatziantoniou
Journal:  Nephron       Date:  2017-07-26       Impact factor: 2.847

Review 9.  Discoidin domain receptors in disease.

Authors:  Corina M Borza; Ambra Pozzi
Journal:  Matrix Biol       Date:  2013-12-19       Impact factor: 11.583

10.  Molecular basis and functional significance of Angiotensin II-induced increase in Discoidin Domain Receptor 2 gene expression in cardiac fibroblasts.

Authors:  Mereena George; Anupama Vijayakumar; Sivadasan Bindu Dhanesh; Jackson James; K Shivakumar
Journal:  J Mol Cell Cardiol       Date:  2015-12-08       Impact factor: 5.000
View more
  1 in total

1.  Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis.

Authors:  Ying Dong; Bi-Xi Tang; Qi Wang; Li-Wei Zhou; Cong Li; Xuan Zhang; Dan-Dan Sun; Xin Sun; Xue-Mei Zhang; Bing Xiong; Jia Li; Hong Shi; Dan-Qi Chen; Yi Zang
Journal:  Acta Pharmacol Sin       Date:  2021-11-24       Impact factor: 7.169
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.